The 31 rating InvestorsObserver gives to Canopy Growth Corp (CGC) stock puts it near the middle of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 58 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, CGC’s 31 overall rating means the stock scores better than 31 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
Is Canopy Growth Corp (CGC) a Good Choice in Drug Manufacturers - Specialty & Generic Friday?
CGC has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on CGC!